/Investor DB

New Leaf Venture Partners — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

Qlaris Bioqlaris.bioinMay 2024 · $24M

Qlaris Bio is a clinical-stage biotechnology company developing therapies for ophthalmology conditions.

BiotechMedical DevicesDedham, US

Thurein Htoo(Executive Officer, Director)inFred Guerard(President & Chief Executive Officer)inBarbara Wirostko(Executive Officer)

BoardWende Hutton(Director)inRonald M. Hunt(Director)Andrew Danielson(Director)

Co-investorsCanaan PartnersCorrelation VenturesMayo Clinic Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Benefit Solutions

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.